Cargando…
Feasibility of Therapeutic Effects of the Cholinergic Anti-Inflammatory Pathway on COVID-19 Symptoms
Autor principal: | Mazloom, Roham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202901/ https://www.ncbi.nlm.nih.gov/pubmed/32378064 http://dx.doi.org/10.1007/s11481-020-09919-6 |
Ejemplares similares
-
Cholinergic anti-inflammatory pathway and COVID-19
por: Mehranfard, Danial, et al.
Publicado: (2022) -
Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19
por: Qin, Zhen, et al.
Publicado: (2021) -
COVID-19-related myocarditis and cholinergic anti-inflammatory pathways
por: Liu, Weike, et al.
Publicado: (2021) -
Cholinergic Anti-Inflammatory Pathway and the Liver
por: Hajiasgharzadeh, Khalil, et al.
Publicado: (2017) -
Impairment of the cholinergic anti-inflammatory pathway in older subjects with severe COVID-19
por: Pomara, Nunzio, et al.
Publicado: (2020)